Norfloxacin and Salmonella Excretion in Acute Gastroenteritis – a 6-Month Follow-up Study
Authors:
- 1 January 1996
- journal article
- clinical trial
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 28 (2) , 177-180
Abstract
In a controlled, randomized, double-blind study, 100 patients (66 women, 34 men; age 18-69 years) with acute salmonellosis were treated with norfloxacin (400 mg) or placebo tablets twice daily for 10 days to compare the effects on the excretion time of salmonella bacteria. In all patients salmonellae were detected in the stools before the start of treatment. The follow-up included 6 stool cultures after the start of treatment: day 3-4, day 12-14, and 4 times during 1-6 months. At 3-4 days there were 98% non-excretors in the norfloxacin group (46/47 patients) compared to 38% (17/45) in the placebo group (p < 0.001). The cumulative 6-month elimination rate in norfloxacin patients at 3-4 days was 72%, which was significantly (p = 0.0001) greater than the 31% in the placebo patients. However, there was no significant difference in the proportion of non-excretors or the elimination rate between the 2 groups at the following visits. Only one patient had an adverse event resulting in discontinuation of the treatment. We conclude that norfloxacin treatment for 10 days decreased the excretion of salmonella bacteria during the first week, but there was no difference in excretion rates 1-6 months after treatment initiation in the treatment versus placebo group.Keywords
This publication has 14 references indexed in Scilit:
- Short-Term Treatment of Traveler's Diarrhea with Norfloxacin: A Double-Blind, Placebo-Controlled Study During Two SeasonsClinical Infectious Diseases, 1993
- Treatment of Traveler's Diarrhea with Ciprofloxacin and LoperamideThe Journal of Infectious Diseases, 1992
- Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled studyAntimicrobial Agents and Chemotherapy, 1992
- Norfloxacin versus placebo for prophylaxis against travellers' diarrhoeaJournal of Antimicrobial Chemotherapy, 1987
- Use of norfloxacin in the treatment of acute diarrheal diseaseThe American Journal of Medicine, 1987
- Spontaneous relapse of naproxen-related nephrotic syndromeThe American Journal of Medicine, 1987
- Effect of Norfloxacin on Human Oropharyngeal and Colonic Microflora and Multiple-dose PharmacokineticsScandinavian Journal of Infectious Diseases, 1987
- Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adultsAntimicrobial Agents and Chemotherapy, 1986
- Norfloxacin A Review of Its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic UseDrugs, 1985
- In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogensAntimicrobial Agents and Chemotherapy, 1983